Patents by Inventor Matthew L. Poulin

Matthew L. Poulin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130116143
    Abstract: The invention generally relates to a novel method and related compositions for detecting and analyzing cancer. More particularly, the invention relates to unique methods, compositions and assays useful for diagnosing and measuring the presence and/or risk of ovarian cancer involving the utilization of various generic and epigenetic biomarkers.
    Type: Application
    Filed: April 19, 2011
    Publication date: May 9, 2013
    Applicant: EPIGENDX, INC.
    Inventors: Liying Yan, Matthew L. Poulin
  • Patent number: 5750365
    Abstract: The present invention relates to novel newt aFGF cDNA and sequence, newt FGFR1 cDNA and sequence, newt FGFR2 cDNA and sequence, newt FGFR3 cDNA and sequence, newt KGFR cDNA and sequence, and CHO-KL cell line (KPTr2-2) expressing newt KGFR. Mutant cell lines (Tr31-5-1 and Tr33-1-2) that become non-responsive to aFGF stimulation are used to differentiate biological activities among different forms of aFGF and other FGF proteins. These novel sequences and cell lines substantially enhance the availability of newt acidic fibroblast growth factor and are useful for producing compositions for promoting growth and/or wound healing.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: May 12, 1998
    Assignee: The Ohio State University Research Foundation
    Inventors: Ing Ming Chiu, Matthew L. Poulin